NH2-(dK)-SVT-(dR)-EDTGTYTC-OH

Catalog Number:
6093
Category:
P4D Peptide
Sequence:
NH2-(dK)-SVT-(dR)-EDTGTYTC-OH
Modifications:
D-amino acids, specifically D-lysine (dK) and D-arginine (dR)
Quantity:
1g
Purity:
>95%
Description:

Peptide P4D (NH₂-(dK)-SVT-(dR)-EDTGTYTC-CONH₂) is a synthetically engineered peptide designed for targeted therapeutic applications, particularly in immunosuppression and autoimmune disease management. Its structure incorporates D-amino acids, specifically D-lysine (dK) and D-arginine (dR), which enhance its stability against enzymatic degradation, thereby prolonging its bioavailability in biological systems.

Functionality and Biological Importance:

Peptide P4D functions by mimicking specific protein surface epitopes, allowing it to interfere with critical protein-protein interactions involved in immune responses. This mimicry enables P4D to inhibit interactions such as the CD4-MHC class II binding, which is pivotal in the activation of CD4⁺ T cells. By disrupting this interaction, P4D effectively reduces T cell proliferation, thereby exhibiting significant immunosuppressive properties. Studies have demonstrated that similar peptides can inhibit CD4⁺ T cell activation, leading to a decrease in immune response intensity.

Applications in Research:

Peptide P4D’s immunosuppressive capabilities make it a valuable tool in various research domains:
  • Autoimmune Disease Models: In experimental autoimmune encephalomyelitis (EAE), a murine model for multiple sclerosis, peptides with analogous structures to P4D have been shown to reduce disease severity. This suggests potential applications in studying therapeutic interventions for autoimmune conditions.
  • Transplantation Studies: The peptide’s ability to prolong skin allograft survival in mice indicates its utility in transplantation research, offering insights into novel strategies for graft acceptance and longevity.
  • Graft-versus-Host Disease (GVHD) Research: Administration of similar peptides has resulted in improved survival rates in murine models of GVHD, highlighting their potential in developing treatments to mitigate this condition.

The incorporation of D-amino acids into P4D’s structure not only enhances its resistance to proteolytic degradation but also ensures its functional integrity in vivo. This structural stability is crucial for maintaining the peptide’s therapeutic efficacy over extended periods.

Peptide P4D represents a promising agent in immunological research, offering a stable and effective means to modulate immune responses. Its applications span from elucidating mechanisms of autoimmune diseases to developing innovative strategies for transplantation and GVHD management.

  • 1 Units in Stock
Ask a Question

$2,000.00

Add to Cart: